Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D and Muscle Protein Turnover: Full Evidence Review

Previous related pageVitamin D and Muscle Protein Turnover: Study SummaryNext related pageVitamin D and Muscle Protein Turnover: Study Summary
Study at a glance

What was studied?

Researchers tested whether vitamin D changes the making and breakdown of muscle proteins. This review compares human supplement trials with experiments in rats and mouse muscle cells. These are different tests, so their results cannot be treated as interchangeable.

What did the human studies find?

The selected trials did not find a clear added benefit for overall muscle protein production, training gains or physical performance under their tested conditions. One small study found an earlier response during the first hour, but no clear benefit across the full four-hour measurement.

What did laboratory studies show?

Some experiments changed protein production or helped preserve muscle size. Results depended on the muscle, the cause of wasting and the form of vitamin D. Preserving cell size did not always mean that more protein was being made.

What remains unresolved?

Direct human evidence about nitrogen balance remains unresolved in this review because relevant full reports could not be adequately assessed. Nitrogen balance helps assess how much protein the whole body retains. This review therefore cannot establish that vitamin D improves whole-body protein retention or recovery from illness.

Read the full article below ↓

This review distinguishes muscle protein production from breakdown, size and whole-body retention. For the shorter account, read Vitamin D and Muscle Protein Turnover: Study Summary.

What this review can answer

Muscle continuously makes and breaks down proteins. A study can measure one part of that turnover without measuring the net amount retained. This review asks what human supplementation trials show about muscle protein synthesis, and how those results compare with selected animal and cell experiments. It is a focused narrative review of ten appraised primary studies, not a pooled estimate or an exhaustive systematic review.

The scope is deliberately limited. Direct human nitrogen-balance evidence remains unresolved because relevant complete reports could not be adequately appraised. Reports available only as abstracts or fragments are not counted as qualified evidence. Their exclusion is not evidence that vitamin D has no effect on nitrogen retention. No claim of improved whole-body retention, protein absorption or clinical recovery follows from this review.

The broader context is Vitamin D and Protein Metabolism. The existing Vitamin D Receptors, Muscle Protein Synthesis and Adaptation: Evidence Review examines receptor biology in greater depth. Here, the central comparison is between human synthesis measurements, functional outcomes and the limits of experimental wasting models.

Synthesis, breakdown and retention are different endpoints

A tracer study follows labelled material into newly made proteins over a defined period. Its fractional synthesis rate describes protein production within the sampled pool. It does not simultaneously establish breakdown, the amount of dietary protein absorbed, or the net retention of protein throughout the body. A larger muscle fibre and a stronger muscle are also separate outcomes.

Nitrogen balance compares nitrogen intake with losses, with attention to collection completeness, diet and other sources of error. It addresses a different question from a muscle biopsy. Likewise, the abundance of a protein associated with degradation is not a direct measurement of the rate of degradation. These distinctions prevent an encouraging molecular signal from becoming an unsupported claim about tissue recovery.

Older adults: a direct synthesis trial without an added effect

Van Vliet and colleagues compared vitamin D, conjugated linoleic acids, their combination and placebo over eight weeks in healthy sedentary older adults. There were 32 completers: eight on placebo, nine on vitamin D, seven on conjugated linoleic acids and eight on the combination. Muscle biopsies and labelled phenylalanine assessed synthesis, including responses during controlled insulin and amino-acid administration.

The baseline-adjusted analysis found no added effect on muscle protein synthesis or grip strength. The combination did not establish a benefit either. These four groups belong to one trial, not four independent confirmations. The study tested a particular supplement combination; it cannot show that every nutritional combination is ineffective.

The small sample was designed around relatively large effects and does not establish equivalence. Severe vitamin D deficiency was excluded. Intravenous amino acids bypass intestinal absorption, so the experiment does not test whether vitamin D improves digestion or absorption of dietary protein. The main report describes 32 completers while the registry records 40 enrolled; the unavailable supplementary flow material prevents a confident reconstruction of every allocation and withdrawal. The interpretation here does not depend on that unavailable material. [S4]

The distinction between relatively healthy trial participants and people with more severe impairment matters when interpreting Vitamin D and Age-Related Decline.

Healthy adults: the full measurement window matters

Revuelta Iniesta and colleagues studied twelve weeks of supplementation in healthy adults, followed by exercise and a whey-protein challenge. Seventeen participants were analysed, nine receiving vitamin D and eight placebo. The principal four-hour synthesis comparison did not show an added supplementation effect: the interaction P value was 0.62. The difference in change was -0.0038 percentage points per hour, with a 95% confidence interval from -0.0357 to 0.0282.

An exploratory first-hour analysis suggested an earlier synthesis response. That is a timing signal within a small trial, not proof of greater total synthesis across the full four-hour period. Nor does it demonstrate sustained muscle gain. Short measurement windows make tracer estimates more sensitive to timing and measurement precision.

Participant accounting differs between the paper, its flow figure and the retrospectively posted registry. Amino-acid presentations also contain inconsistencies. These limitations make a strong clinical interpretation inappropriate. Ageing, illness and injury were not tested populations in this experiment, even if the authors discuss them as possible future applications. [S5]

Training and physical performance provide separate tests

Agergaard and colleagues enrolled forty younger and older men in a sixteen-week comparison of vitamin D plus calcium against calcium alone, with resistance training during the final twelve weeks. Thirty-four were analysed. The study found no significant added hypertrophy or strength response from vitamin D. A change in a myostatin-related transcript in younger participants did not establish an additional functional benefit.

All six withdrawals occurred in the vitamin D groups, leaving seven supplemented and ten control participants in each age stratum. Small groups, baseline differences and analysis of those who completed the intervention limit confidence. The older participants were not generally deficient, and the trial measured neither synthesis and breakdown together nor nitrogen balance. [S3]

Houston and colleagues provide a larger functional comparison: 136 older adults with low physical function were randomized to vitamin D or placebo for twelve months, and 129 completed the study. Vitamin D status increased, but muscle power, strength and physical-performance outcomes did not show a clear added benefit. The primary leg-power difference was -4.00 watts, with a standard error of 5.26 watts and P=0.45. The standard error should not be read as a confidence interval.

Screening and subsequent vitamin D assays differed, and background supplementation complicates interpretation. The published correction changes the conversion of 30 ng/mL to 75 nmol/L; it does not create a second trial. This functional result does not measure protein flux and cannot settle whether a particular molecular response occurred. [S9] The distinctions are relevant to Vitamin D and Muscle Function.

Receptor manipulation and deficiency experiments answer other questions

Bass and colleagues greatly increased vitamin D receptor expression in one rat muscle and compared it with a control muscle in the same animal. In seven animals, mixed-muscle synthesis was approximately 17.3% per day versus 10.2% per day after ten days. Fibre growth accompanied the synthesis response. A degradation-associated marker also increased, so the finding does not establish that breakdown was switched off.

This was an unusually large receptor manipulation in one muscle, not a human oral supplementation trial. The associated human training analysis was observational. It cannot establish that taking vitamin D causes the same response. The discrepancy between the paper and figure in the exact receptor increase is not resolved here, and that magnitude is not used in this review. [S1]

Wassner and colleagues compared vitamin D deficiency and supplementation in young rats, with feeding and calcium comparisons. Selected measurements supported greater myofibrillar degradation in deficient animals and a reduction after vitamin D. However, whole-protein synthesis and degradation comparisons were not statistically clear. Deficient rats whose calcium was maintained could continue growing, underlining the importance of mineral status.

Food intake, calcium and insulin-related effects complicate attribution to a direct muscle action. Methylhistidine measurements also have tissue-specificity and excretion limitations. These rat experiments support a conditional biological relationship, not a human nitrogen-retention effect. [S7] Vitamin D and Skeletal Muscle Function provides the tissue context.

Increasing receptor abundance changes the response machinery itself. Vitamin D Receptors explains why that intervention differs from changing the supply of vitamin D.

Ageing rats: tissue proportions do not measure protein flux

Domingues-Faria and colleagues followed older rats on a normal or vitamin D-free diet for nine months. Ten animals were initially assigned to each group; seven controls and nine depleted animals were included in the final analyses. Animals that died or developed tumours or renal insufficiency were excluded. Depletion was associated with changes in body composition, the tibialis muscle-to-body-weight ratio and Notch-related proteins, while the soleus ratio did not show the same response.

A ratio can change because its numerator, denominator or both change. It cannot automatically be reported as an equivalent loss of absolute muscle mass. The experiment did not measure synthesis and breakdown rates, strength, nitrogen retention or recovery after injury. Changes in Notch-associated proteins do not establish that restoring that pathway would rescue the phenotype. [S8]

Wasting models depend on the stressor and vitamin D form

Teixeira and colleagues found that vitamin D3 helped preserve the diameter of cultured mouse muscle cells exposed to interleukin-6. Under the selected conditions, this was not accompanied by a clear increase in their protein-synthesis assay or Akt-mTOR signalling. Protection was lost after reducing receptor expression. The same study did not demonstrate equivalent protection against dexamethasone-induced wasting. Its three independent experiments support a specific cell-model result, not a clinical treatment effect. [S10]

Karnia and colleagues studied rats exposed to dexamethasone or cold stress. Vitamin D selectively protected soleus muscle weight in the dexamethasone comparison, but did not generally rescue other muscle or body-mass losses. Cold stress increased corticosterone without reproducing the same wasting pattern. The morphology measurements do not establish synthesis, degradation or nitrogen balance, and the small groups limit precision. [S12]

Hirunsai and Srikuea compared cholecalciferol, or vitamin D3, with calcitriol, the activated hormone, in an angiotensin-II mouse muscle-cell model. Vitamin D3 limited diameter loss under selected conditions while calcitriol worsened it. These findings show why different vitamin D forms should not be treated as interchangeable experimental exposures.

The experiment did not measure synthesis or degradation rates, and static measurements of LC3 and p62 do not establish autophagic flux, the rate at which material passes through the recycling pathway. Results in cultured cells do not establish either benefit from vitamin D3 or harm from prescribed calcitriol in people. [S13]

The conversion of vitamin D3 into the activated hormone is part of Vitamin D Activation. Directly exposing a cell to either compound does not reproduce the regulation of both compounds in a person.

What remains unresolved

Direct human nitrogen balance remains an open question in this review. Full primary reports needed to assess the older human candidates were unavailable or insufficiently accessible for an adequate appraisal. Abstracts, indexed statements and isolated table fragments were excluded from the qualified evidence set. Possible overlap between older reports also remains unresolved.

The included trials cannot settle effects in severe deficiency, clinical malnutrition or recovery from illness. Findings from healthy adults cannot simply be transferred to those populations. Conversely, positive animal or cell findings cannot fill the missing human evidence. This is a documented limitation of this review, not a claim that no relevant evidence exists anywhere.

Conclusion

Vitamin D-related manipulations can change selected muscle synthesis, degradation-associated signals and tissue-size outcomes in experimental models. The human trials included here did not demonstrate a clear added benefit across their principal synthesis, training or performance outcomes, although one small study suggested an earlier response within the measurement period.

The defensible conclusion is conditional: effects depend on population, vitamin D form, biological stress and the endpoint actually measured. These studies do not establish improved whole-body protein retention, treatment of muscle wasting or recovery from illness. They provide no basis here for an individual supplement regimen. The unresolved human nitrogen-balance evidence remains explicitly outside the completed appraisal.

Sources and publication details

[S1] Bass JJ et al. Overexpression of the vitamin D receptor (VDR) induces skeletal muscle hypertrophy. Molecular Metabolism.2020;42:101059. DOI: 10.1016/j.molmet.2020.101059. PMID: 32771696.

[S3] Agergaard J et al. Does vitamin-D intake during resistance training improve the skeletal muscle hypertrophic and strength response in young and elderly men?: a randomized controlled trial. Nutrition & Metabolism.2015;12:32. DOI: 10.1186/s12986-015-0029-y. PMID: 26430465.

[S4] van Vliet S,Fappi A,Reeds DN,Mittendorfer B. No independent or combined effects of vitamin D and conjugated linoleic acids on muscle protein synthesis in older adults: a randomized, double-blind, placebo-controlled clinical trial. Am J Clin Nutr.2020;112:1382 to 1389. DOI: 10.1093/ajcn/nqaa240. PMID: 32860399.

[S5] Revuelta Iniesta R et al. Long-term effects of vitamin D supplementation on myofibrillar protein synthesis rates in resting and exercised fed skeletal muscle of healthy adults. The Journal of Nutritional Physiology.2026;6:100032. DOI: 10.1016/j.jnphys.2026.100032.

[S7] Wassner SJ,Li JB,Sperduto A,Norman ME. Vitamin D Deficiency, hypocalcemia, and increased skeletal muscle degradation in rats. J Clin Invest.1983;72:102 to 112. DOI: 10.1172/JCI110947. PMID: 6308041.

[S8] Domingues-Faria C et al. Vitamin D deficiency down-regulates Notch pathway contributing to skeletal muscle atrophy in old wistar rats. Nutrition & Metabolism.2014;11:47. DOI: 10.1186/1743-7075-11-47. PMID: 25317198.

[S9] Houston DK et al. Vitamin D Supplementation and Muscle Power, Strength and Physical Performance in Older Adults: A Randomized Controlled Trial. Am J Clin Nutr.2023;117:1086 to 1095. DOI: 10.1016/j.ajcnut.2023.04.021. PMID: 37084814.

[S10] Teixeira MA et al. Cholecalciferol (vitamin D3) has a direct protective activity against interleukin 6-induced atrophy in C2C12 myotubes. Aging.2021;13:4895 to 4910. DOI: 10.18632/aging.202669. PMID: 33618332.

[S12] Karnia MJ et al. The Positive Impact of Vitamin D on Glucocorticoid-Dependent Skeletal Muscle Atrophy. Nutrients.2021;13:936. DOI: 10.3390/nu13030936. PMID: 33799389.

[S13] Hirunsai M,Srikuea R. Differential effects of cholecalciferol and calcitriol on muscle proteolysis and oxidative stress in angiotensin II-induced C2C12 myotube atrophy. Physiological Reports.2024;12:e16011. DOI: 10.14814/phy2.16011. PMID: 38627219.

Houston DK and colleagues. Corrigendum to ‘Vitamin D Supplementation and Muscle Power, Strength and Physical Performance in Older Adults: A Randomized Controlled Trial’ [The American Journal of Clinical Nutrition, Volume 117, Issue 6, June 2023, Pages 1086 to 1095]. The American Journal of Clinical Nutrition. 2023;118(2):486. DOI: 10.1016/j.ajcnut.2023.06.004. PMID: 37331702. The corrected conversion is 30 ng/mL to 75 nmol/L.

Related reading

Physiology

Vitamin D and Protein Metabolism

Explore how vitamin D relates to protein metabolism, including muscle protein turnover, gene regulation, calcium signalling, connective tissue support, and life stage needs.

Read more →

Original sources

Source

Does vitamin-D intake during resistance training improve the skeletal muscle hypertrophic and strength response in young and elderly men? – a randomized controlled trial

Published in Nutrition & Metabolism (2015).

Publication details

[S3] Agergaard J et al. Does vitamin-D intake during resistance training improve the skeletal muscle hypertrophic and strength response in young and elderly men?: a randomized controlled trial. Nutrition & Metabolism.2015;12:32. DOI: 10.1186/s12986-015-0029-y. PMID: 26430465.

Read more →
Source

No independent or combined effects of vitamin D and conjugated linoleic acids on muscle protein synthesis in older adults: a randomized, double-blind, placebo-controlled clinical trial

Published in Am J Clin Nutr (2020).

Publication details

[S4] van Vliet S,Fappi A,Reeds DN,Mittendorfer B. No independent or combined effects of vitamin D and conjugated linoleic acids on muscle protein synthesis in older adults: a randomized, double-blind, placebo-controlled clinical trial. Am J Clin Nutr.2020;112:1382 to 1389. DOI: 10.1093/ajcn/nqaa240. PMID: 32860399.

Read more →
Source

Long-term effects of vitamin D supplementation on myofibrillar protein synthesis rates in resting and exercised fed skeletal muscle of healthy adults

Published in The Journal of Nutritional Physiology (2026).

Publication details

[S5] Revuelta Iniesta R et al. Long-term effects of vitamin D supplementation on myofibrillar protein synthesis rates in resting and exercised fed skeletal muscle of healthy adults. The Journal of Nutritional Physiology.2026;6:100032. DOI: 10.1016/j.jnphys.2026.100032.

Read more →
Source

Vitamin D deficiency down-regulates Notch pathway contributing to skeletal muscle atrophy in old wistar rats

The aim of this study was to evaluate how vitamin D deficiency induces skeletal muscle atrophy in old rats through a reduction in Notch pathway activity and proliferation potential in muscle.

Publication details

[S8] Domingues-Faria C et al. Vitamin D deficiency down-regulates Notch pathway contributing to skeletal muscle atrophy in old wistar rats. Nutrition & Metabolism.2014;11:47. DOI: 10.1186/1743-7075-11-47. PMID: 25317198.

Read more →
Source

Cholecalciferol (vitamin D3) has a direct protective activity against interleukin 6-induced atrophy in C2C12 myotubes

This study aimed to clarify whether cholecalciferol (VD3) too, the non-hydroxylated upstream metabolite, has a direct effect on muscle cells.

Publication details

[S10] Teixeira MA et al. Cholecalciferol (vitamin D3) has a direct protective activity against interleukin 6-induced atrophy in C2C12 myotubes. Aging.2021;13:4895 to 4910. DOI: 10.18632/aging.202669. PMID: 33618332.

Read more →
Source

Corrigendum to ‘Vitamin D Supplementation and Muscle Power, Strength and Physical Performance in Older Adults: A Randomized Controlled Trial’ [The American Journal of Clinical Nutrition, Volume 117, Issue 6, June 2023, Pages 1086–1095]

Published in The American Journal of Clinical Nutrition (2023).

Publication details

Houston DK and colleagues. Corrigendum to ‘Vitamin D Supplementation and Muscle Power, Strength and Physical Performance in Older Adults: A Randomized Controlled Trial’ [The American Journal of Clinical Nutrition, Volume 117, Issue 6, June 2023, Pages 1086 to 1095]. The American Journal of Clinical Nutrition. 2023;118(2):486. DOI: 10.1016/j.ajcnut.2023.06.004. PMID: 37331702. The corrected conversion is 30 ng/mL to 75 nmol/L.

Read more →